Global Data-Driven Quality Assurance in Pharma Manufacturing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI08256292

Publication Date:

August 8, 2025

Pages:

119

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

According to this study, the global Data-Driven Quality Assurance in Pharma Manufacturing market size will reach US$ 5026 million by 2031.
This report mainly focuses on data-driven quality assurance in pharma manufacturing market. Data-driven quality assurance (DD-QA) refers to the process of pharmaceutical production, through real-time collection, analysis and use of production data (such as process parameters, equipment status, environmental monitoring, quality inspection, etc.), to monitor, predict and optimize production quality in a scientific and automated manner to ensure that drugs comply with regulatory requirements (such as GMP) and improve production efficiency. The core is to use data as the basis for quality decision-making, reduce human intervention, and improve the accuracy and traceability of quality control.
United States market for Data-Driven Quality Assurance in Pharma Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Data-Driven Quality Assurance in Pharma Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Data-Driven Quality Assurance in Pharma Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Data-Driven Quality Assurance in Pharma Manufacturing players cover FirstEigen, EVERSANA, Ideagen, Incepbio, Exor International S.p.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淒ata-Driven Quality Assurance in Pharma Manufacturing Industry Forecast鈥� looks at past sales and reviews total world Data-Driven Quality Assurance in Pharma Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Data-Driven Quality Assurance in Pharma Manufacturing sales for 2025 through 2031. With Data-Driven Quality Assurance in Pharma Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Data-Driven Quality Assurance in Pharma Manufacturing industry.
This Insight Report provides a comprehensive analysis of the global Data-Driven Quality Assurance in Pharma Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Data-Driven Quality Assurance in Pharma Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Data-Driven Quality Assurance in Pharma Manufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Data-Driven Quality Assurance in Pharma Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Data-Driven Quality Assurance in Pharma Manufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Data-Driven Quality Assurance in Pharma Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Real-time Monitoring
Statistical Quality Control
Others
Segmentation by Application:
Process Development and Optimization
Production Process Control
Quality Inspection and Release
Supply Chain and Materials Management
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
FirstEigen
EVERSANA
Ideagen
Incepbio
Exor International S.p.A.
ComplianceQuest
Vimachem
Proscia
Amplelogic
Freyr Solutions
Thermo Fisher SampleManager LIMS
Dassault Syst猫mes

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size (2020-2031)
2.1.2 Data-Driven Quality Assurance in Pharma Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Data-Driven Quality Assurance in Pharma Manufacturing by Country/Region (2020, 2024 & 2031)
2.2 Data-Driven Quality Assurance in Pharma Manufacturing Segment by Type
2.2.1 Real-time Monitoring
2.2.2 Statistical Quality Control
2.2.3 Others
2.3 Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type
2.3.1 Data-Driven Quality Assurance in Pharma Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Market Share by Type (2020-2025)
2.4 Data-Driven Quality Assurance in Pharma Manufacturing Segment by Application
2.4.1 Process Development and Optimization
2.4.2 Production Process Control
2.4.3 Quality Inspection and Release
2.4.4 Supply Chain and Materials Management
2.4.5 Others
2.5 Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application
2.5.1 Data-Driven Quality Assurance in Pharma Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Market Share by Application (2020-2025)
3 Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Player
3.1 Data-Driven Quality Assurance in Pharma Manufacturing Market Size Market Share by Player
3.1.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Player (2020-2025)
3.1.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Market Share by Player (2020-2025)
3.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Data-Driven Quality Assurance in Pharma Manufacturing by Region
4.1 Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Region (2020-2025)
4.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth (2020-2025)
4.4 APAC Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth (2020-2025)
4.5 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth (2020-2025)
4.6 Middle East & Africa Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Country (2020-2025)
5.2 Americas Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2025)
5.3 Americas Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Region (2020-2025)
6.2 APAC Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2025)
6.3 APAC Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Country (2020-2025)
7.2 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2025)
7.3 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Data-Driven Quality Assurance in Pharma Manufacturing by Region (2020-2025)
8.2 Middle East & Africa Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2025)
8.3 Middle East & Africa Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Forecast
10.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Forecast by Region (2026-2031)
10.1.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Forecast by Region (2026-2031)
10.1.2 Americas Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.1.3 APAC Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.1.4 Europe Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.1.5 Middle East & Africa Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.2 Americas Data-Driven Quality Assurance in Pharma Manufacturing Forecast by Country (2026-2031)
10.2.1 United States Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.2.2 Canada Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.2.3 Mexico Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.2.4 Brazil Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.3 APAC Data-Driven Quality Assurance in Pharma Manufacturing Forecast by Region (2026-2031)
10.3.1 China Data-Driven Quality Assurance in Pharma Manufacturing Market Forecast
10.3.2 Japan Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.3.3 Korea Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.3.4 Southeast Asia Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.3.5 India Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.3.6 Australia Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.4 Europe Data-Driven Quality Assurance in Pharma Manufacturing Forecast by Country (2026-2031)
10.4.1 Germany Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.4.2 France Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.4.3 UK Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.4.4 Italy Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.4.5 Russia Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.5 Middle East & Africa Data-Driven Quality Assurance in Pharma Manufacturing Forecast by Region (2026-2031)
10.5.1 Egypt Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.5.2 South Africa Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.5.3 Israel Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.5.4 Turkey Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
10.6 Global Data-Driven Quality Assurance in Pharma Manufacturing Forecast by Type (2026-2031)
10.7 Global Data-Driven Quality Assurance in Pharma Manufacturing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Data-Driven Quality Assurance in Pharma Manufacturing Forecast
11 Key Players Analysis
11.1 FirstEigen
11.1.1 FirstEigen Company Information
11.1.2 FirstEigen Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.1.3 FirstEigen Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 FirstEigen Main Business Overview
11.1.5 FirstEigen Latest Developments
11.2 EVERSANA
11.2.1 EVERSANA Company Information
11.2.2 EVERSANA Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.2.3 EVERSANA Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 EVERSANA Main Business Overview
11.2.5 EVERSANA Latest Developments
11.3 Ideagen
11.3.1 Ideagen Company Information
11.3.2 Ideagen Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.3.3 Ideagen Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Ideagen Main Business Overview
11.3.5 Ideagen Latest Developments
11.4 Incepbio
11.4.1 Incepbio Company Information
11.4.2 Incepbio Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.4.3 Incepbio Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Incepbio Main Business Overview
11.4.5 Incepbio Latest Developments
11.5 Exor International S.p.A.
11.5.1 Exor International S.p.A. Company Information
11.5.2 Exor International S.p.A. Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.5.3 Exor International S.p.A. Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Exor International S.p.A. Main Business Overview
11.5.5 Exor International S.p.A. Latest Developments
11.6 ComplianceQuest
11.6.1 ComplianceQuest Company Information
11.6.2 ComplianceQuest Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.6.3 ComplianceQuest Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 ComplianceQuest Main Business Overview
11.6.5 ComplianceQuest Latest Developments
11.7 Vimachem
11.7.1 Vimachem Company Information
11.7.2 Vimachem Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.7.3 Vimachem Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Vimachem Main Business Overview
11.7.5 Vimachem Latest Developments
11.8 Proscia
11.8.1 Proscia Company Information
11.8.2 Proscia Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.8.3 Proscia Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Proscia Main Business Overview
11.8.5 Proscia Latest Developments
11.9 Amplelogic
11.9.1 Amplelogic Company Information
11.9.2 Amplelogic Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.9.3 Amplelogic Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Amplelogic Main Business Overview
11.9.5 Amplelogic Latest Developments
11.10 Freyr Solutions
11.10.1 Freyr Solutions Company Information
11.10.2 Freyr Solutions Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.10.3 Freyr Solutions Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Freyr Solutions Main Business Overview
11.10.5 Freyr Solutions Latest Developments
11.11 Thermo Fisher SampleManager LIMS
11.11.1 Thermo Fisher SampleManager LIMS Company Information
11.11.2 Thermo Fisher SampleManager LIMS Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.11.3 Thermo Fisher SampleManager LIMS Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Thermo Fisher SampleManager LIMS Main Business Overview
11.11.5 Thermo Fisher SampleManager LIMS Latest Developments
11.12 Dassault Syst猫mes
11.12.1 Dassault Syst猫mes Company Information
11.12.2 Dassault Syst猫mes Data-Driven Quality Assurance in Pharma Manufacturing Product Offered
11.12.3 Dassault Syst猫mes Data-Driven Quality Assurance in Pharma Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Dassault Syst猫mes Main Business Overview
11.12.5 Dassault Syst猫mes Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂